JAZZ FY 2013 Earnings — Jazz Pharmaceuticals plc Revenue & Financial Results | Market Cap Arena

JAZZJazz Pharmaceuticals plc

$11B

FY 2013 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$872M+48.9% YoY

Gross Profit

$770M88.3% margin

Operating Income

$340M39.0% margin

Net Income

$216M24.8% margin

EPS (Diluted)

$3.51

Cash Flow

Operating Cash Flow

$284M

Free Cash Flow

$272M

Stock-Based Comp.

$45M

Balance Sheet

Total Assets

$2.2B

Total Liabilities

$943M

Stockholders' Equity

$1.3B

Cash & Equivalents

$637M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$872M	$586M	+48.9%
Gross Profit	$770M	$508M	+51.8%
Operating Income	$340M	$198M	+72.0%
Net Income	$216M	$289M	-25.0%